Answers are grounded in this paper and cite their sources.
This analysis investigates interleukins and PTPN22 gene variants in immune thrombocytopenia patients, revealing no significant findings.
Background: Immune thrombocytopenia (ITP) is a common acquired hematologic autoimmune illness. Objectives: this work goals to examine the role of interleukins (ILs) and polymorphisms of PTPN22 gene in the progression and pathogenesis of ITP. Methods: 50 ITP patients were included. Human serum levels of antinuclear antibodies (ANA), anti-platelet antibody (PA-Ab) and IL-40 were measured using enzyme linked immunosorbent assay (ELISA). Gene expression of Protein tyrosine phosphatase non-receptor type 22 (PTPN22) were determined using Real-time polymerase chain reaction (RT-PCR), while the sequencing of this gene was determined using Sanger method and genotyping was detected using conventional PCR. Result: No significant variations were observed in serum level of ANA, PA-Ab and IL-40, PTPN22 gene expression and its single nucleotide polymorphism (rs2488457) in acute and chronic cases of ITP.
No takes yet. Share an insight, caveat, or question.
Lamam et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: